Middle East welcomes Korean doctors, medicine
05-Mar-15, Business Korea
Korean medical institutions and pharmaceuticals have made inroads into the Middle East. Over 100 projects about public health and medicine estimated to be worth US$36.7 billion in total will be carried out in the countries on President Park’s Middle East tour lists.
Image: Business Korea
Thanks to the President’s business-oriented trip this week, four Korean pharmaceutical companies signed MOUs with Saudi firm Sudair Pharmaceutical Co. to export products, including antibiotics and anticancer drugs, for the next five years. The Ministry of Health and Wellfare estimated deals worth about 200 billion won ($182.3 million). The firms are JW Holdings, Chong Kun Dang Holdings, Boryung Pharm, and BC World Pharm Co.
Additionally, Korea’s Yonsei University Severance Hospital will be in charge of treatment at a medical center specializing in women’s cancers. The hospital, scheduled to open in 2016, is under construction by a Saudi health care firm, and will house about 150 patients. Also, Korea’s Green Cross Laboratories has signed an MOU to establish a clinical laboratory at the medical center.